Influenza Hemagglutinin (HA) Peptide: Precision Epitope Tag for Immunoprecipitation and Protein Purification

Introduction & Principle: The Power of the HA Tag Peptide

The Influenza Hemagglutinin (HA) Peptide (sequence: YPYDVPDYA) is a synthetic, nine-amino-acid epitope tag derived from the human influenza hemagglutinin protein. As a molecular biology peptide tag, it enables high-specificity detection and purification of HA-tagged fusion proteins in diverse research workflows. The HA tag sequence is recognized by anti-HA antibodies, facilitating both capture and competitive elution of fusion proteins, and is widely adopted in protein-protein interaction studies, immunoprecipitation, and protein purification assays.

With exceptional solubility (≥55.1 mg/mL in DMSO, ≥100.4 mg/mL in ethanol, and ≥46.2 mg/mL in water), the HA peptide supports a broad range of buffer conditions. Supplied by APExBIO at >98% purity (confirmed by HPLC and mass spectrometry), it ensures reproducible binding and elution performance, underpinning advanced experimental designs in molecular biology and translational research. The hemagglutinin tag’s compatibility with a range of detection and purification platforms makes it indispensable for researchers requiring precision and scalability.

Applied Workflow: Step-by-Step Protocol Enhancements with the HA Peptide

1. Construct Design & Expression

Begin by engineering your protein of interest with an HA tag—using the well-characterized ha tag dna sequence or ha tag nucleotide sequence—at the N- or C-terminus. This ensures reproducibility in downstream detection and isolation steps. Expression can be performed in mammalian, insect, or yeast systems, leveraging the broad utility of the epitope tag for protein detection.

2. Cell Lysis & Sample Preparation

Lyse cells under conditions that preserve protein-protein interactions, using non-denaturing buffers compatible with both the HA fusion protein elution peptide and your chosen anti-HA antibody or magnetic bead system. The robust solubility of the HA peptide allows direct preparation of stock solutions in water or compatible solvents, ensuring easy integration into experimental buffers.

3. Immunoprecipitation with Anti-HA Antibody

Incubate cleared lysates with anti-HA antibody-conjugated magnetic beads or agarose resin. The competitive binding to Anti-HA antibody by the HA tag enables selective capture of HA-tagged proteins and their interacting partners. Wash beads thoroughly to remove non-specifically bound proteins, optimizing stringency as needed.

4. Competitive Elution Using HA Peptide

Add the synthetic Influenza Hemagglutinin (HA) Peptide to the bead-protein complexes. The peptide competes with the HA tag on your fusion protein for antibody binding, displacing the target protein into solution. Typical elution conditions use 1–2 mg/mL peptide in buffer, with a 15–30 minute incubation at 4°C. The peptide’s high purity and solubility ensure efficient and gentle elution, preserving protein integrity for downstream analyses.

5. Downstream Analysis

Eluted proteins are ready for SDS-PAGE, western blotting, mass spectrometry, or functional assays. The minimal size of the HA tag (nine amino acids) minimizes interference with protein folding and function, making it ideal for applications such as exosome biogenesis studies, as illustrated in the reference study by Wei et al., Cell Research (2021).

Advanced Applications and Comparative Advantages

Exosome Biogenesis and Protein-Protein Interaction Studies

The HA tag peptide is a cornerstone of advanced research into complex cellular pathways. For example, in the landmark study on ESCRT-independent exosome pathways (Wei et al., 2021), researchers used HA tags to monitor and purify key protein complexes regulating multivesicular endosome (MVE) dynamics. The competitive elution capacity of the HA peptide allowed the isolation of low-abundance protein assemblies, revealing mechanisms of RAB GTPase-mediated exosome biogenesis. Such studies underscore the protein purification tag’s role in unraveling intricate signaling networks and post-translational modification landscapes.

Comparative Performance: Data-Driven Insights

• Purity & Specificity: APExBIO's HA peptide delivers >98% purity, minimizing background and false positives in co-immunoprecipitation (co-IP) and pull-down assays.
• Solubility: With solubility up to 100.4 mg/mL in ethanol, the peptide is suitable for concentrated elution protocols and diverse buffer formulations.
• Compatibility: The HA tag sequence is recognized by multiple commercial anti-HA antibodies and bead platforms, providing flexibility in experimental design.
• Minimal Interference: The nine-residue tag rarely disrupts protein structure/function, supporting functional assays and structural biology investigations.

Complementary and Extended Resources

For a strategic overview of the HA tag’s role in translational research, "Unleashing Precision in Translational Research" discusses how the HA peptide enhances workflow efficiency and clinical relevance, complementing the practical focus here. Another in-depth analysis, "Influenza Hemagglutinin (HA) Peptide: Precision Tag for P...", extends this discussion with case studies on robust solubility and high-purity detection, directly supporting the data-driven insights above. Finally, "Precision Epitope Tag for Affinity Purification" offers a mechanistic perspective on competitive binding and streamlined elution, contrasting with our applied workflow emphasis.

Troubleshooting and Optimization Tips for HA Tag Workflows

• Low Yield During Elution: Increase peptide concentration (up to 5 mg/mL) or extend incubation time. Confirm buffer compatibility with the Influenza Hemagglutinin (HA) Peptide’s solubility profile; avoid strong denaturants or incompatible salts that may reduce competitive binding efficiency.
• High Background in IP: Use highly purified anti-HA antibodies and pre-clear lysates with control beads. The exceptional purity of APExBIO’s peptide reduces non-specific elution, but optimization of wash stringency may be necessary.
• Protein Degradation: Always perform elution at 4°C and include protease inhibitors. Prepare fresh peptide solutions as long-term storage in solution may degrade the epitope, impacting binding.
• Low Signal in Detection: Confirm the correct ha tag nucleotide sequence was cloned and expressed. Validate antibody reactivity and consider secondary detection strategies (e.g., enhanced chemiluminescence, fluorescent secondary antibodies).
• Buffer Precipitation: For challenging formulations, dissolve the HA peptide first in DMSO or ethanol before dilution into aqueous buffers, leveraging its high solubility in multiple solvents.

Future Outlook: Next-Generation Applications of the HA Epitope Tag

The landscape for protein tagging and purification is rapidly evolving. As multi-omics workflows and high-throughput interactome mapping become routine, the Influenza Hemagglutinin (HA) Peptide will remain indispensable. Its compatibility with automated immunoprecipitation platforms and emerging magnetic bead technologies positions it for expanded roles in clinical proteomics, single-cell analyses, and post-translational modification mapping.

Further advances in affinity tag engineering may integrate tandem epitope tags or orthogonal elution strategies, but the HA tag’s minimal size, robust specificity, and proven track record—exemplified by its role in defining exosome biology (Wei et al., 2021)—ensure its continued relevance. The resource base, including articles like "Precision Tag for Advanced Protein Analysis", illustrates the HA peptide’s enduring value and adaptability.

Conclusion

From its origins as the influenza hemagglutinin epitope to its central place in modern molecular biology, the HA tag peptide exemplifies the convergence of precision, scalability, and experimental flexibility. APExBIO's Influenza Hemagglutinin (HA) Peptide (product link) offers unmatched performance and reliability for protein purification, interaction studies, and advanced immunoprecipitation with Anti-HA antibody workflows. As research challenges grow in complexity, the HA tag stands ready to enable the next wave of biological discovery.